SENSEX NIFTY

Religare Capital Markets

Oct 22, 2014 at 19:50 | Source: PTI
In a circular, the capital market regulator said that a stockbroker, who is not a bank, can take proprietary open position limits in currency derivatives.
Oct 22, 2014 at 16:25 | Source: PTI
After hearing the petition, filed by the country's largest real estate developer last week, the Tribunal adjourned the matter till October 30 next week, as it sought a response from capital markets regulator Sebi on DLF's plea for an interim relief.
Oct 22, 2014 at 13:46 | Source: CNBC-TV18
Veterans Ramesh Damani, Member of BSE, Samir Arora, Founder & Fund Manager of Helios Capital, and Manish Chokhani, Chairman, TPG Growth India, discuss their expectations from Samvat 2071
Oct 22, 2014 at 13:45 | Source: Moneycontrol.com
The realty giant appealed for interim relief from a three-year ban from accessing capital markets by the regulator. DLF lodged its appeal with the SAT, which will conduct its next hearing on October 30.
Oct 22, 2014 at 10:34 | Source: Moneycontrol.com
Equity and Debt Mutual Funds surge as market rallied for the third consecutive session on Tuesday with the benchmark Nifty closing above the 7900 level supported by banks, metals, auto and capital goods stocks.
Oct 22, 2014 at 09:36 | Source: CNBC-TV18
Sukhani prefers to stay with Nifty stocks like IT, pharma, FMCG and capital group, L&T, BHEL, everything except the Bank Nifty for the day.
Oct 21, 2014 at 15:16 | Source: Moneycontrol.com
Religare Capital is bullish on UltraTech Cement and has recommended buy rating on the stock with a target of Rs 2930 in its October 18, 2014 research report.
Oct 21, 2014 at 14:01 | Source: Moneycontrol.com
Religare Capital is bullish on HCL Technologies and has recommended buy rating on the stock with a target of Rs 1700 in its October 17, 2014 research report.
Oct 21, 2014 at 09:39 | Source: Moneycontrol.com
According to Arihant Capital, if Nifty trades above 7910 level then it is likely to test 7950 7980 levels. On the downside below the gap area next support for Nifty is at 7780 7750 levels.
Oct 21, 2014 at 09:23 | Source: CNBC-TV18
Shane Oliver believes the markets have seen quite a good correction and a lot of bad news has already been factored in. Therefore, the worst is over and the bull market is likely to resume.
Messages on Religare Capital Markets »

Web Messenger

Platinum Member

245448 Followers

Indian indices  

Source:NDTV Profit - 2:30 p.m. Tirthankar Patnaik of Religare Capital Markets says that Nifty has could run up by another 100-150 points before the fundamentals catch up. (Track stocks). All the sectoral indices, except the pharma, are trading higher. Gail India, Tech

4.55 PM Mar 6th

cleverman

Platinum Member

92 Followers

Ranbaxy Labs  

also the stock will have a downside of around 10-15 per cent from these levels. We recommend a sell on the stock," adds Nangra. Arvind Bothra, Vice President, institutional research, Religare Capital Markets, says, "we expect significant negative impact on stock price following this news and reiterate

8.15 PM Jan 24th

BSE/NSE Announcer

Platinum Member

4674 Followers

Crompton Greave  

"). This Advertisement should be read in conjunction with, and in continuation of, the Public Announcement (PA") published on July 04, 2013 and corrigenda to the PA published on July 16, 2013 and November 09,2013 to the shareholders of Crompton Greaves Limited ("Target Company")Religare Capital Markets Ltd

5.45 PM Jan 16th

Web Messenger

Platinum Member

245448 Followers

Ipca Labs  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

245448 Followers

Glenmark  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

245448 Followers

News Now  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on market movement in 2014. ET Now: Last day of 2013, how does that really set stage for what your outlook is in the initial part

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

245448 Followers

Infosys  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on Infosys. ET Now: What makes you bullish on Infosys? Dr Tirthankar Patnaik: We are positive on the whole IT sector and therefore

3.25 PM Dec 31st 2013

DLF  

The central bank will hike repo rate, or the rate at which banks borrow from the central bank (Reserve Bank of India), by a total of 50 basis points (bps) till FY14-end, believes Tirthankar Patnaik, executive vice president- institutional sales, Religare Capital Markets. So it will sock to real

11.52 AM Oct 25th 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.47 PM Oct 23rd 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.46 PM Oct 23rd 2013

News across the web »
Jul 10, 2014 at 10:00 | Source: NDTV Profit
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.